Related references
Note: Only part of the references are listed.Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor
Dan You et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance
Jinqi Liu et al.
PLOS ONE (2019)
Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer
Ping Wu et al.
STRUCTURE (2019)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function
Sairy Hernandez et al.
CELL REPORTS (2018)
Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors
Rajeev S. Bhide et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Oxadiazoles in Medicinal Chemistry
Jonas Bostrom et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Hematopoietic progenitor kinase 1 negatively regulates T cell receptor signaling and T cell-mediated immune responses
Jr-Wen Shui et al.
NATURE IMMUNOLOGY (2007)